1.Department of Neurology,
Tongji Hospital, Tongji Medical College, Huazhong University of Science
and Technology, Wuhan 430030, China；Department of Neurology,
Inner Mongolia Hospital, Hohhot 010017, China; 2.Department of Neurology,
Tongji Hospital, Tongji Medical College, Huazhong University of Science
and Technology, Wuhan 430030, China;
Abstract：In order to explore the role of cyclin-dependent kinase 4 (cdk4) in neurodegenerative diseases, lentiviral-delivered RNA interference (RNAi) was used to silence the expression of the murine cdk4 gene in vitro. Three cdk4-shRNAs of mouse and a negative sequence were designed. After synthesis and annealing, double strand oligonucleotides were cloned into a linearized pSIH1-H1-copGFP shRNA vector. It was confirmed by polymerase chain reaction (PCR) and sequencing that three pairs of cdk4-shRNAs and a negative shRNA were correctly inserted into the pSIH1-H1-copGFP vector. The above recombinants were transfected by lipofectamine into BV-2 cells. The gene silencing efficacy rates of the 3 targets were compared by Western blotting. The cdk4-siRNA2 was the most effective in silencing cdk4. The optimized pSIH1-cdk4-siRNA2 and pSIH-negative-siRNA were co-transfected into 293T cells with the lentiviral packaging plasmids respectively. The culture supernatant was harvested and condensed at the 24th and 48thh after transfection. Interference efficiency of the lentivirus expressing cdk4-siRNA was determined by reverse transcriptase-PCR (RT-PCR) and Western blotting in BV-2 cells. Lentivector-mediated RNAi could efficiently down-regulate the expression of the murine cdk4 gene in vitro, which provides a potential tool for studying and treating cdk4-related diseases.
Buée L, Bussière T, Buée-Scherrer V, Delacourte A, Hof P R. Tau protein isoforms, phosphorylationand role in neurodegenerative disorders. Brain Res Brain Res Rev, 2000, 33(1): 95―130 doi: 10.1016/S0165-0173(00)00019-9
Giovanni A, Wirtz-Brugger F, Keramaris E, Slack R, Park D S. Involvement of cell cycle elements, cyclin-dependentkinases, pRb, and E2F x DP, in B-amyloid-induced neuronal death. J Biol Chem, 1999, 274(27): 19011―19016 doi: 10.1074/jbc.274.27.19011
Vincent I, Pae C I, Hallows J L. The cell cycle and human neurodegenerative disease. Prog Cell Cycle Res, 2003, 5: 31―41
Smith P D, O'Hare M J, Park D S. Emerging pathogenic role for cyclin dependent kinasesin neurodegeneration. Cell Cycle, 2004, 3(3): 289―291
Jorda E G, Verdaguer E, Canudas A M, Jiménez A, Bruna A, Caelles C, Bravo R, Escubedo E, Pubill D, Camarasa J, Pallàs M, Camins A. Neuroprotectiveaction of flavopiridol, a cyclin-dependent kinase inhibitor, in colchicine-inducedapoptosis. Neuropharmacology, 2003, 45(5): 672―683 doi: 10.1016/S0028-3908(03)00204-1
Elbashir S M, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interferencein cultured mammalian cells. Nature, 2001, 411(6836): 494―498 doi: 10.1038/35078107
Wilda M, Fuchs U, Wössmann W, Borkhardt A. Killingof leukemic cells with a BCR/ABL fusion gene by RNA interference (RNAi). Oncogene, 2002, 21(37): 5716―5724 doi: 10.1038/sj.onc.1205653
Jacque J M, Triques K, Stevenson M. Modulation of HIV-1 replication by RNA interference. Nature, 2002, 418(6896): 435―438 doi: 10.1038/nature00896
Shlomai A, Shaul Y. Inhibition of hepatitis Bvirus expression replication by RNA interference. Hepatology, 2003, 37(4): 764―770 doi: 10.1053/jhep.2003.50146
Cann A J. RNA viruses. A practical approach. Oxford: OxfordUniversity Press, 2000
Albertin G, Ruggero M, Guidolin D, Nussdorfer G G. Gene silencing of human RAMP2 mediated by short-interfering RNA. Int J Mol Med, 2006, 18(4): 531―535
Hommel J D, Sears R M, Georgescu D, Simmons D L, DiLeone R J. Local gene knockdown in thebrain using viral-mediated RNA interference. Nat Med, 2003, 9(12): 1539―1544 doi: 10.1038/nm964
Stewart S A, Dykxhoorn D M, Palliser D, Mizuno H, Yu E Y, An D S, Sabatini D M, Chen I S, Hahn W C, Sharp P A, Weinberg R A, Novina C D. Lentivirus-delivered stable gene silencing by RNAi inprimary cells. RNA, 2003, 9(4): 493―501 doi: 10.1261/rna.2192803
Ong W Y, Kumar U, Switzer R C, Sidhu A, Suresh G, Hu C Y, Patel S C. Neurodegeneration in Niemann-Picktype C disease mice. Exp Brain Res, 2001, 141(2): 218―231 doi: 10.1007/s002210100870
Khatib Z A, Matsushime H, Valentine M, Shapiro D N, Sherr C J, Look A T. Coamplification of the CDK4 gene with MDM2 and GLI inhuman sarcomas. Cancer Res, 1993, 53(22): 5535―5541
Bu B T, Wang X Z, Zhang Y H. Activation of cdk4/cyclin D1 pathway participates inthe neuronal degeneration of murine niemann-pick disease type C. Xi Bao Sheng Wu Xue Za Zhi, 2005, 27(4): 435―440 (in Chinese)
McCaffrey A P, Nakai H, Pandey K, Huang Z, Salazar F H, Xu H, Wieland S F, Marion P L, Kay M A. Inhibitionof hepatitis B virus in mice by RNA interference. Nat Biotechnol, 2003, 21(6): 639―644 doi: 10.1038/nbt824
Rubinson D A, Dillon C P, Kwiatkowski A V, Sievers C, Yang L, Kopinja J, Rooney D L, Zhang M, Ihrig M M, McManus M T, Gertler F B, Scott M L, Van Parijs L. Alentivirus-based system to functionally silence genes in primary mammaliancells, stem cells and transgenic mice by RNA interference. Nat Genet, 2003, 33(3): 401―406 doi: 10.1038/ng1117
Sinn P L, Sauter S L, McCray P B Jr. Gene therapy progress and prospects: development of improvedlentiviral and retroviral vectors- design, biosafety, and production. Gene Ther, 2005, 12(14): 1089―1098 doi: 10.1038/sj.gt.3302570
Dull T, Zufferey R, Kelly M, Mandel R J, Nguyen M, Trono D, Naldini L. Athird-generation lentivirus vector with a conditional packaging system. J Virol, 1998, 72(11): 8463―8471
Pfeifer A, Eigenbrod S, Al-Khadra S, Hofmann A, Mitteregger G, Moser M, Bertsch U, Kretzschmar H. Lentivector-mediated RNAiefficiently suppresses prion protein and prolongs survival of scrapie-infectedmice. J Clin Invest, 2006, 116(12): 3204―3210 doi: 10.1172/JCI29236
Yang Z, Cloud A, Hughes D, Johnson L F. Stable inhibition of human thymidylate synthase expression followingretroviral introduction of an siRNA gene. Cancer Gene Ther, 2006, 13(1): 107―114 doi: 10.1038/sj.cgt.7700880
